Table 1.
Baseline patient characteristics
| Data | Value | |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 69.83 (9.06) | |
| Sex | ||
| Male | 24 | |
| Female | 5 | |
| Child-Pugh_Classification | ||
| Child A | 19 | |
| Child B | 10 | |
| Serum AFP level (ng/mL) | ||
| MELD score | ||
| Mean (SD) | 9.77 (3.06) | |
| No. of nodules | ||
| 1 | 11 | |
| 2 | 6 | |
| 3 | 8 | |
| 4 | 3 | |
| > = 5 | 1 | |
| Lesion size (mm) | mRECIST | |
| Mean (SD) | 32.33 (21.24) | |
| Range | 16.25 to 44.5 | |
| Lesion margins | ||
| Capsulated | 33 | |
| Infiltrative | 31 | |
| Previous of TACES | ||
| Yes | 15 | |
| No | 14 | |
| Epirubicin hydrochloride dose (mg) | ||
| Median | 40 | |
| Range | 25 to 50 | |
| Interval between baseline CT and TACE (d) | ||
| Mean (SD) | 15.72 (14.01) | |